4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-15-009818
Chief Technology Officer sold 50,000 shares at an average $8.90 ($444,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Technology Officer | 2015-12-28 | Sale | −11,000 | $9.27 | $101,915 | 181,450 | D |
| Kidron Miriam Chief Technology Officer | 2015-12-29 | Sale | −15,000 | $9.08 | $136,178 | 166,450 | D |
| Kidron Miriam Chief Technology Officer | 2015-12-30 | Sale | −24,000 | $8.61 | $206,707 | 142,450 | D |
| Open-market sales · 50,000 sh · avg $8.90 · $444,800 | |||||||
Loading xslF345X03/f4122815kidron_oramedpharma.xml…